Seoul:Egyptian Drug Authority (EDA) Chairman Ali El Ghamrawy met with senior officials from the Korea-Africa Foundation (KAF), led by President Ambassador Kim Young-Chae, to discuss enhancing pharmaceutical cooperation and exploring investment opportunities. The meeting took place during the EDA's participation in the International Coalition of Medicines Regulatory Authorities (ICMRA) summit in Seoul.

According to State Information Service Egypt, the discussions aimed to leverage South Korea's advanced expertise and technology to strengthen communication between Korean and Egyptian companies in pharmaceuticals and biotechnology. The meeting also explored strategic partnerships to attract new investments into Egypt's pharmaceutical sector.

The EDA highlighted Egypt's strategic advantages, including its advanced manufacturing capabilities and regulatory infrastructure, positioning it as a regional hub and gateway for Korean companies into African markets. This provides opportunities for Korean direct investment and industrial integration.

Additionally, El Ghamrawy met with Euntae Kim, CEO of South Korean company Bhomegen, to discuss cooperation in technology transfer and expertise exchange, focusing on developing Egypt's pharmaceutical and medical sectors. These efforts align with the EDA's commitment to fostering institutional partnerships with South Korean counterparts to enhance Egypt's pharmaceutical sector competitiveness and presence in international markets.